Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55,781,559
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
10,646,057
-
Shares change
-
+33,499
-
Total reported value, excl. options
-
$139,604,845
-
Value change
-
-$678,194
-
Number of buys
-
15
-
Number of sells
-
-18
-
Price
-
$13.18
Significant Holders of Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) as of Q1 2021
48 filings reported holding FHTX - Foghorn Therapeutics Inc. - COMMON STOCK as of Q1 2021.
Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,646,057 shares
of 55,781,559 outstanding shares and own 19.09% of the company stock.
Largest 10 shareholders include FMR LLC (2,573,034 shares), Artal Group S.A. (1,720,720 shares), Euclidean Capital LLC (1,261,261 shares), Cormorant Asset Management, LP (1,000,000 shares), Monashee Investment Management LLC (530,581 shares), Alphabet Inc. (500,901 shares), BlackRock Inc. (432,125 shares), VANGUARD GROUP INC (407,287 shares), MORGAN STANLEY (393,722 shares), and Birchview Capital, LP (314,143 shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.